1
|
Millogo M, Soubeiga ST, Bazie BVJT, Zohoncon TM, Ouattara AK, Yonli AT, Simpore J. Disputed paternity presumption in Burkina Faso: determination of the biological fathers of children using ABO-rhesus/hemoglobin electrophoresis and STR assays. J Genet Eng Biotechnol 2021; 19:130. [PMID: 34459998 PMCID: PMC8405726 DOI: 10.1186/s43141-021-00221-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2021] [Accepted: 07/30/2021] [Indexed: 12/04/2022]
Abstract
BACKGROUND In resource-limited countries, ABO, HLA, MNS, Kells, and hemoglobin electrophoresis are classic tests for the resolution of paternity disputes due to their affordable cost. The limitations of these tests in cases of disputed paternity require the use of Short Tandem Repeats (STR) for their certification. This study aimed to determine the biological fathers of children using ABO-rhesus/hemoglobin electrophoresis and STR assays in Burkina Faso, West Africa. RESULTS Of the fourteen trios studied, the ABO-rhesus/hemoglobin electrophoresis analysis revealed ten probable inclusion cases, three exclusion cases, and one undetermined paternity. DNA STR analysis found five inclusions of paternity out of the ten probable inclusions with ABO-rhesus/hemoglobin electrophoresis assay versus nine exclusions of paternity. CONCLUSION This study showed that the implementation of the analysis of short tandem repeat is required to resolve increasing disputed filiation cases in Burkina Faso.
Collapse
Affiliation(s)
- Missa Millogo
- Direction of Scientific and Technical Police, Ouagadougou, Burkina Faso
- Laboratory of Molecular Biology and Genetics (LABIOGENE) of University Joseph Ki-Zerbo, P.O. 03 BOX, 7021 Ouaga 03, Ouagadougou, Burkina Faso
| | - Serge Theophile Soubeiga
- Laboratory of Molecular Biology and Genetics (LABIOGENE) of University Joseph Ki-Zerbo, P.O. 03 BOX, 7021 Ouaga 03, Ouagadougou, Burkina Faso.
- Biomolecular Research Centre Pietro Annigoni (CERBA)), P.O. 01 BOX 364, Ouagadougou, Ouaga 01, Burkina Faso.
- Research Institute of Health Sciences (IRSS)), P.O. 03. BOX 7192, Ouagadougou, Ouaga 03, Burkina Faso.
| | - Bapio Valerie Jean Telesphore Bazie
- Laboratory of Molecular Biology and Genetics (LABIOGENE) of University Joseph Ki-Zerbo, P.O. 03 BOX, 7021 Ouaga 03, Ouagadougou, Burkina Faso
- Biomolecular Research Centre Pietro Annigoni (CERBA)), P.O. 01 BOX 364, Ouagadougou, Ouaga 01, Burkina Faso
- Research Institute of Applied and Technical Sciences (IRSAT)), P.O. 03 BOX 7047, Ouagadougou, Ouaga 03, Burkina Faso
| | - Theodora Mahoukede Zohoncon
- Laboratory of Molecular Biology and Genetics (LABIOGENE) of University Joseph Ki-Zerbo, P.O. 03 BOX, 7021 Ouaga 03, Ouagadougou, Burkina Faso
- Biomolecular Research Centre Pietro Annigoni (CERBA)), P.O. 01 BOX 364, Ouagadougou, Ouaga 01, Burkina Faso
- University of Saint Thomas d'Aquin (USTA)), P.O. 06 BOX 10212, Ouagadougou, Ouaga 06, Burkina Faso
| | - Abdoul Karim Ouattara
- Laboratory of Molecular Biology and Genetics (LABIOGENE) of University Joseph Ki-Zerbo, P.O. 03 BOX, 7021 Ouaga 03, Ouagadougou, Burkina Faso
- Biomolecular Research Centre Pietro Annigoni (CERBA)), P.O. 01 BOX 364, Ouagadougou, Ouaga 01, Burkina Faso
| | - Albert Theophane Yonli
- Laboratory of Molecular Biology and Genetics (LABIOGENE) of University Joseph Ki-Zerbo, P.O. 03 BOX, 7021 Ouaga 03, Ouagadougou, Burkina Faso
- Biomolecular Research Centre Pietro Annigoni (CERBA)), P.O. 01 BOX 364, Ouagadougou, Ouaga 01, Burkina Faso
| | - Jacques Simpore
- Laboratory of Molecular Biology and Genetics (LABIOGENE) of University Joseph Ki-Zerbo, P.O. 03 BOX, 7021 Ouaga 03, Ouagadougou, Burkina Faso
- Biomolecular Research Centre Pietro Annigoni (CERBA)), P.O. 01 BOX 364, Ouagadougou, Ouaga 01, Burkina Faso
- University of Saint Thomas d'Aquin (USTA)), P.O. 06 BOX 10212, Ouagadougou, Ouaga 06, Burkina Faso
| |
Collapse
|
2
|
Servonnet A, Leclercq E, Delacour H, Ceppa F. [HLA-B*5701 and abacavir hypersensitivity reaction]. ACTA ACUST UNITED AC 2009; 58:e95-100. [PMID: 19243901 DOI: 10.1016/j.patbio.2008.12.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2008] [Accepted: 12/24/2008] [Indexed: 11/18/2022]
Abstract
A potentially life-threatening hypersensitive reaction occurs in association with initiation of HIV nucleoside analogue abacavir therapy in 4 to 8% of patients. Preliminary studies appear to confirm the role of the immune system in abacavir hypersensitivity. The reaction is possibly the result of presentation of drug peptides onto HLA, that may induce a pathogenic T-cell response. Hypersensitivity reaction to abacavir is strongly associated with the presence of the HLA-B*5701 allele and prospective HLA-B*5701 genetic screening has now been instituted in clinical practice to reduce the risk of hypersensitivity reaction.
Collapse
Affiliation(s)
- A Servonnet
- Laboratoire de biochimie, hôpital d'instruction des armées Bégin, 69, avenue de Paris, 94163 Saint-Mandé cedex, France.
| | | | | | | |
Collapse
|